KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Cash & Current Investments (2016 - 2025)

Neogenomics (NEO) has disclosed Cash & Current Investments for 16 consecutive years, with $164.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Current Investments fell 57.68% year-over-year to $164.1 million, compared with a TTM value of $164.1 million through Sep 2025, down 57.68%, and an annual FY2024 reading of $386.8 million, down 6.83% over the prior year.
  • Cash & Current Investments was $164.1 million for Q3 2025 at Neogenomics, up from $154.7 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $612.0 million in Q1 2021 and bottomed at $154.7 million in Q2 2025.
  • Average Cash & Current Investments over 5 years is $359.9 million, with a median of $355.1 million recorded in 2024.
  • The sharpest move saw Cash & Current Investments soared 609.5% in 2021, then plummeted 57.68% in 2025.
  • Year by year, Cash & Current Investments stood at $515.4 million in 2021, then dropped by 15.02% to $438.0 million in 2022, then dropped by 5.2% to $415.2 million in 2023, then fell by 6.83% to $386.8 million in 2024, then crashed by 57.58% to $164.1 million in 2025.
  • Business Quant data shows Cash & Current Investments for NEO at $164.1 million in Q3 2025, $154.7 million in Q2 2025, and $346.2 million in Q1 2025.